Back to available technologies

Antidote Controlled Inhibitors of Cell Surface Targets

The present invention relates, in general, to receptors and to platelet aggregation and, in particular, to a method of inhibiting platelet aggregation using an aptamer that binds to and inhibits the activity of a receptor, such as glycoprotein IIb/IIIa (gpIIb/IIIa), and to aptamers suitable for use in such a method. The invention also relates to antidotes to antiplatelet agents and to methods of using such antidotes to reverse aptamer-induced platelet inhibition. The invention further relates to von Willebrand Factor (VWF) inhibitors, and antidotes therefore, and to methods of using same.

Duke File (IDF) Number



  • Sullenger, Bruce
  • Nimjee, Shahid
  • Rusconi, Christopher

For more information please contact


School of Medicine (SOM)